Darbepoetin alfa for anemia with myelodysplastic syndrome.

about

Darbepoetin alfa for anemia with myelodysplastic syndrome.

Item

http://www.wikidata.org/entity/Q38314705

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Darbepoetin alfa for anemia with myelodysplastic syndrome.

@en

type

Item

label

Darbepoetin alfa for anemia with myelodysplastic syndrome.

@en

prefLabel

Darbepoetin alfa for anemia with myelodysplastic syndrome.

@en

P1476

Darbepoetin alfa for anemia with myelodysplastic syndrome

@en

P2093

David J Seastone

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Prognosis of myelodysplastic syndromes

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.

Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.

A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.

A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes

P304

139-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474086.2015.1000854

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aaron T Gerds

P577

2015-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25579702

http://www.w3.org/2001/XMLSchema#string

P921

Darbepoetin alfa

Darbepoetin alfa for anemia with myelodysplastic syndrome.

about

Darbepoetin alfa for anemia with myelodysplastic syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921